Compounds and methods for treating diseases mediated by protease activated receptors
US9422262B2 · kind B2 · utility
1Cited by
2References
7Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Sep 23, 2011 |
| Grant date | Aug 23, 2016 |
| Priority date | — |
| Expiry date | Dec 19, 2031 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D307/68
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the use of a compound of Formula I for the treatment of protease-activated receptor mediated diseases by the administration of a compound of Formula I or a prodrug or metabolite thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.